Search

Your search keyword '"Landi, D"' showing total 16 results

Search Constraints

Start Over You searched for: Author "Landi, D" Remove constraint Author: "Landi, D" Topic humans Remove constraint Topic: humans
16 results on '"Landi, D"'

Search Results

1. Signs and symptoms of COVID-19 in patients with multiple sclerosis

2. Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

3. Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study

4. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

5. Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab

6. CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab

7. Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study

8. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

9. Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy

10. Cladribine vs other drugs in MS: Merging randomized trial with real-life data

11. Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

12. First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study

13. MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study

14. Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders

15. No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML

16. DNA Repair and Cell Cycle Control Genes and the Risk of Young-Onset Lung Cancer

Catalog

Books, media, physical & digital resources